结论OD - PT D融合蛋白对K562细胞有明显的抑制作用，为进一步探讨慢性粒细胞白血病新的治疗手段提供了实验依据。
Conclusion OD-PTD fusion protein can significantly inhibit the proliferation of K562 cells, which provides an experimental basis for new therapy of chronic myeloid leukemia.
当前治疗对一些慢性粒细胞白血病病人无效，医生正在研究其他可能有所帮助的药物。
Doctors are studying other drugs that may help CML patients who do not respond to current treatment.
当前治疗对一些慢性粒细胞白血病病人无效，医生正在研究其他可能有所帮助的药物。
Doctors are studying other drugs that may help CML patients who do not respond to current treatment.
应用推荐